162 related articles for article (PubMed ID: 38785302)
1. Risk factors for cardio-cerebrovascular events among patients undergoing continuous ambulatory peritoneal dialysis and their association with serum magnesium.
Li P; Lv T; Xu L; Yu W; Lu Y; Li Y; Hao J
Ren Fail; 2024 Dec; 46(1):2355354. PubMed ID: 38785302
[TBL] [Abstract][Full Text] [Related]
2. Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients.
Su X; Zhang K; Guo F; Yuan B; Wang C; Xiao L; Wang J; Huang H
Clin Biochem; 2013 Oct; 46(15):1410-3. PubMed ID: 23796881
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
4. Serum uric acid level as a cardio-cerebrovascular event risk factor in middle-aged and non-obese Chinese men.
Li ZJ; Yi CJ; Li J; Tang N
Oncotarget; 2017 Apr; 8(15):24110-24118. PubMed ID: 28445982
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
6. Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration.
Katopodis KP; Koliousi EL; Andrikos EK; Pappas MV; Elisaf MS; Siamopoulos KC
Artif Organs; 2003 Sep; 27(9):853-7. PubMed ID: 12940910
[TBL] [Abstract][Full Text] [Related]
7. U-shaped relationship between uric acid and residual renal function decline in continuous ambulatory peritoneal dialysis patients.
Hsieh YP; Yang Y; Chang CC; Kor CT; Wen YK; Chiu PF; Lin CC
Nephrology (Carlton); 2017 Jun; 22(6):427-435. PubMed ID: 26370323
[TBL] [Abstract][Full Text] [Related]
8. Correlation of serum omentin-1 level with clinical features and major adverse cardiac and cerebral events in patients undergoing continuous ambulatory peritoneal dialysis.
Yao C; Ou J; Zhou L; Liu J
Scand J Clin Lab Invest; 2023 Apr; 83(2):119-124. PubMed ID: 36847753
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation and parathyroid hormone influence the cytosolic calcium levels of erythrocytes in peritoneal dialysis patients.
Sahin E; Goçmen AY; Gümüşlü S; Sahin M; Koçak H; Tuncer M
Clin Lab; 2011; 57(7-8):551-7. PubMed ID: 21888020
[TBL] [Abstract][Full Text] [Related]
10. Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution.
Ejaz AA; McShane AP; Gandhi VC; Leehey DJ; Ing TS
Perit Dial Int; 1995; 15(1):61-4. PubMed ID: 7734563
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis.
Paniagua R; Frías Y; de Ventura MJ; Rodríguez E; Hurtado ME; Alcántara G; Vázquez R; Ortiz R; Salcedo M; Rios ME; Kaji J; Amato D
Perit Dial Int; 2003; 23(2):132-7. PubMed ID: 12713079
[TBL] [Abstract][Full Text] [Related]
12. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
[TBL] [Abstract][Full Text] [Related]
13. The cardiovascular risk factor profiles among end-stage renal failure patients treated with continuous ambulatory peritoneal dialysis and intermittent hemodialysis.
Zamiah SAKS; Draman CR; Seman MR; Safhan AF; Rozalina R; Nik Ruzni NI
Saudi J Kidney Dis Transpl; 2018; 29(1):114-119. PubMed ID: 29456216
[TBL] [Abstract][Full Text] [Related]
14. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Woo J; Chan IH; Lui SF; Sanderson JE; Li PK
Am J Kidney Dis; 2005 Apr; 45(4):715-29. PubMed ID: 15806475
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-497/fibroblast growth factor-23 axis, a predictive indictor for decreased major adverse cardiac and cerebral event risk in end-stage renal disease patients who underwent continuous ambulatory peritoneal dialysis.
Liu D; Zhou S; Mao H
J Clin Lab Anal; 2020 Jun; 34(6):e23220. PubMed ID: 32077150
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patients.
Yang C; Ma X; Zhao W; Chen Y; Lin H; Luo D; Zhang J; Lou T; Peng Y; Peng H
Ren Fail; 2020 Nov; 42(1):447-454. PubMed ID: 32401146
[No Abstract] [Full Text] [Related]
17. Fibroblast growth factor-23 correlates with advanced disease conditions and predicts high risk of major adverse cardiac and cerebral events in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis.
Xu L; Hu X; Chen W
J Nephrol; 2019 Apr; 32(2):307-314. PubMed ID: 30465136
[TBL] [Abstract][Full Text] [Related]
18. Platelet-to-lymphocyte ratio is associated with cardiovascular disease in continuous ambulatory peritoneal dialysis patients.
Chen T; Yang M
Int Immunopharmacol; 2020 Jan; 78():106063. PubMed ID: 31835088
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of modality failure with higher serum uric acid level in continuous ambulatory peritoneal dialysis patients: a prospective cohort study.
He S; Xiong Q; Li L; Lin X; Zhao J; Guo X; He Y; Liang W; Ying C; Zuo X
Ren Fail; 2022 Dec; 44(1):272-281. PubMed ID: 35172675
[TBL] [Abstract][Full Text] [Related]
20. Relationship between uric acid and technique failure in patients on continuous ambulatory peritoneal dialysis: a long-term observational cohort study.
Hsieh YP; Chang CC; Kor CT; Yang Y; Wen YK; Chiu PF; Lin CC
BMJ Open; 2017 Apr; 7(4):e010816. PubMed ID: 28389481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
